A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence

A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence

The past decade has seen the increasing influence and relevance of real-world data (RWD) and real-world evidence (RWE) in healthcare decision making. The value added by RWD/RWE has prompted the pharmaceutical industry to develop high performing systems and practices to harness the power of evidence...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Kristoffer Larsen, Ryan N. Walton, Mohamed Elsayed, Andrey Ipatov, Faye Townsend-Holyoake, Sebastian F. A. Axelsson, Nacho Quinones, Rudiger Papsch, Jennifer Givens, Alexander Bedenkov, Michael Seewald
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Frontiers Media S.A. 2023-10-01
Reeks:	Frontiers in Pharmacology
Onderwerpen:	real-world evidence (RWE) real-world data (RWD) evidence capabilities medical affairs
Online toegang:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1233617/full

Gelijkaardige items

Real-world evidence market: key players and key segments
door: A. R. Kasimova, et al.
Gepubliceerd in: (2022-01-01)

Resolution based on the results of the IV annual scientific-practical conference "Real clinical practice. Modernity and the future"
door: A. S. Kolbin
Gepubliceerd in: (2023-12-01)

Resolution based on the results of the III annual scientific and practical conference «Real clinical practice in a changing world. Challenges and Solutions»
door: A. S. Kolbin
Gepubliceerd in: (2022-11-01)

ICH Reflection paper on proposed international harmonization of real-world evidence terminology and convergence of general principles regarding planning and reporting of studies using real-world data, with a focus on effectiveness of drugs
door: K. S. Radaeva, et al.
Gepubliceerd in: (2023-10-01)

Educational pharmacoepidemiology and "Real-World Knowledge"
door: R. A. Bontsevich
Gepubliceerd in: (2025-01-01)

Resolution based on the results of the conference: "RWD/ RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow"
door: A. S. Kolbin
Gepubliceerd in: (2021-08-01)

Review of data sources used in real-world traumatology and orthopedic
door: I. U. Zolotukhina, et al.
Gepubliceerd in: (2023-12-01)

A brief report of real-world evidence development (RWD/RWE) in 2021: United States, Russia, and the Eurasian Economic Union (EAEU)
door: A. S. Kolbin, et al.
Gepubliceerd in: (2022-01-01)

Resolution based on the results of the V annual scientific-practical conference "RWD/RWE. Possible and real"
door: A. S. Kolbin, et al.
Gepubliceerd in: (2024-12-01)

NICE guidance to working with real-world data
door: A. Sh. Motrinchuk, et al.
Gepubliceerd in: (2023-01-01)

Role of RWD / RWE in health technology assessment
door: V. G. Borovskaya, et al.
Gepubliceerd in: (2023-03-01)

Combining real-world data with randomized controlled trials results in better information oncology decision making
door: T. A. Usmanova, et al.
Gepubliceerd in: (2022-08-01)

The role of real world data and real world evidence in health technology assessment
door: E. A. Novoderezhkina, et al.
Gepubliceerd in: (2022-10-01)

Peculiarities of real-world data application for health technology assessment in Asian countries
door: B. B. Kondratyeva, et al.
Gepubliceerd in: (2024-02-01)

Registers as the basis for data collection and evidence building
door: A. V. Ivanov
Gepubliceerd in: (2021-08-01)

Legal particularities of AI technology usage in real-world data formation
door: V. S. Malichenko, et al.
Gepubliceerd in: (2024-02-01)

HARPER — protocol template for real-world trials for evaluating treatment efficacy
door: S. M. Mukhina, et al.
Gepubliceerd in: (2023-01-01)

Regional administrative data and their role in planning, programming and controlling at regional level
door: Irene Marzona, et al.
Gepubliceerd in: (2024-04-01)

Use of transportability methods for real-world evidence generation: a review of current applications
door: Natalie S Levy, et al.
Gepubliceerd in: (2024-10-01)

Real-world data: principles of use in decision making and in health technology assessment
door: V. V. Omelyanovskiy, et al.
Gepubliceerd in: (2023-07-01)

NeuroBlu: a natural language processing (NLP) electronic health record (EHR) data analytic tool to generate real-world evidence in mental healthcare
door: R. Patel, et al.
Gepubliceerd in: (2022-06-01)

Maintaining patient registries, on the basis of which regulatory authorities can make decisions regarding medicines
door: A. V. Ivanov, et al.
Gepubliceerd in: (2023-03-01)

Real-world evidence for regulatory decision-making: updated guidance from around the world
door: Leah Burns, et al.
Gepubliceerd in: (2023-10-01)

HER2-directed therapy following ctDNA-identified ERBB2 amplification in patients with advanced gastroesophageal cancer: exploration of real-world outcomes
door: S. Chakrabarti, et al.
Gepubliceerd in: (2024-06-01)

Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study
door: Seiya Ohtani, et al.
Gepubliceerd in: (2023-11-01)

Power BI as an auxiliary tool for biostatistics
door: N. Yu. Dmitrieva
Gepubliceerd in: (2022-01-01)

Editorial: Real-world data and real-world evidence in lung cancer
door: Valerio Gristina, et al.
Gepubliceerd in: (2024-06-01)

Dados administrativos brasileiros para pesquisa do mundo real: Método de Linkage Determinística e Harmonização OMOP CDM
door: Thales Brendon Castano Silva, et al.
Gepubliceerd in: (2023-11-01)

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?
door: Alejandra Castanon, et al.
Gepubliceerd in: (2024-05-01)

Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)
door: Soowoo Back, et al.
Gepubliceerd in: (2024-06-01)

Real World Evidence: methodological issues and opportunities from the European Health Data Space
door: Stelios Kympouropoulos
Gepubliceerd in: (2023-08-01)

RETRACTED: ESMO Guidance for reporting oncology real-world evidence (GROW)
door: A. Sh. Motrinchuk, et al.
Gepubliceerd in: (2024-04-01)

The relevance of the real-world evidence in research, clinical, and regulatory decision making
door: Valton Costa, et al.
Gepubliceerd in: (2025-02-01)

Recommendations for developing drug use definitions with an emphasis on real-world data sources
door: A. S. Motrinchuk, et al.
Gepubliceerd in: (2024-09-01)

Evaluating treatments in rare indications warrants a Bayesian approach
door: Emma K. Mackay, et al.
Gepubliceerd in: (2023-09-01)

Laying the Foundation for Real-World Evidence Studies of Psoriatic Disease in Newfoundland and Labrador
door: Winifred Badaiki, et al.
Gepubliceerd in: (2022-09-01)

DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union
door: K. S. Radaeva, et al.
Gepubliceerd in: (2023-01-01)

Advancing the role of real-world evidence in comparative effectiveness research
door: Monica Daigl, et al.
Gepubliceerd in: (2024-10-01)

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021
door: Catherine Lau, et al.
Gepubliceerd in: (2022-10-01)

Real-World Evidence to Reinforce Clinical Trial Evidence in Health Technology Assessment: A Critical Review of Real-World Evidence Requirements from Seven Countries and Recommendations to Improve Acceptance
door: Katia Thokagevistk, et al.
Gepubliceerd in: (2024-05-01)